JJDC

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

16 Mar 2026

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.

JJDC

- Life Sciences
1(12 months)
jnjinnovation.com/home
Update Information

More venture news

Earth Blox
19 Mar 2026
Earth Blox secures £6m in funding led by PXN Ventures to turn natural risk into financial insights
EquityClimate
Chalkie
20 Mar 2026
Chalkie lands a £3m round from TriplePoint Ventures for curriculum-aligned lesson planning software
EquityEducation
Regeno
20 Mar 2026
Regeno secures £420k in funding from SFC and One Planet Capital for ground-level serviceable wind turbines
EquityEnergy

JJDC

Investment Portfolio

Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

More venture news

Earth Blox secures £6m in funding led by PXN Ventures to turn natural risk into financial insights

Chalkie lands a £3m round from TriplePoint Ventures for curriculum-aligned lesson planning software

Regeno secures £420k in funding from SFC and One Planet Capital for ground-level serviceable wind turbines